Announcements Trials
Browse Landscape

Phase

Phase NA 27Phase 2 9Phase 4 5Phase EARLY_PHASE1 2Phase 3 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other 1

Conditions

Prostatic Neoplasms 502Urinary Bladder Neoplasms 139Carcinoma, Renal Cell 116Neoplasms 66Kidney Neoplasms 53Non-Muscle Invasive Bladder Neoplasms 43Neoplasm Metastasis 38Carcinoma, Transitional Cell 38Breast Neoplasms 30Testicular Neoplasms 28Recurrence 20Wilms Tumor 18Parkinson Disease 4, Autosomal Dominant Lewy Body 14Pain 13Ovarian Neoplasms 13Urologic Neoplasms 12Testicular Germ Cell Tumor 12Teratoma 12Seminoma 12Multiple Myeloma 12Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Ovarian Epithelial 11Carcinoma 11Urogenital Neoplasms 10Neuroblastoma 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10

Interventions

Risedronic Acid 1Psychiatric Rehabilitation 1Biofeedback, Psychology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Hyperplasia × Genitourinary × Clear all
NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

National Cancer Institute (NCI)

Phase 3 Completed
800 enrolled
GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00426777 2012-02-03

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

CMX Research

Phase 3 Completed
160 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡